ARCHIVES

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Reader Finds Letter insulting to Ethic Group

February 16, 1996

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

April 19, 2002

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989